Education
About Us
Working with TipRanks
Follow Us
Monogram Orthopaedics Inc (MGRM)
NASDAQ:MGRM
RESEARCH TOOLSreports
Total Valuation
Monogram Orthopaedics Inc has a market cap or net worth of . The enterprise value is $69.23M.
Market Cap
Enterprise Value$69.23M
Share Statistics
Monogram Orthopaedics Inc has 35.29M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding35.29M
Owned by Insiders0.82%
Owned by Instutions0.24%
Financial Efficiency
Monogram Orthopaedics Inc’s return on equity (ROE) is -1.13 and return on invested capital (ROIC) is -93.54%.
Return on Equity (ROE)-112.58%
Return on Assets (ROA)-91.89%
Return on Invested Capital (ROIC)-93.54%
Return on Capital Employed (ROCE)-94.34%
Revenue Per Employee$0
Profits Per Employee-$604,740.778
Employee Count27
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Monogram Orthopaedics Inc is -4.73. Monogram Orthopaedics Inc’s PEG ratio is 0.26.
PE Ratio-4.73
PS Ratio0.00
PB Ratio5.32
Price to Fair Value5.32
Price to FCF-5.49
Price to Operating Cash Flow-5.53
PEG Ratio0.26
Income Statement
In the last 12 months, Monogram Orthopaedics Inc had revenue of $0.00 and earned -$16.33M in profits. Earnings per share was -$0.38.
Revenue$0.00
Gross Profit-$212.74K
Operating Income-$15.31M
Pretax Income-$16.33M
Net Income-$16.33M
EBITDA-14.88M
Earnings Per Share (EPS)-0.38
Cash Flow
In the last 12 months, operating cash flow was -$13.97M and capital expenditures -$84.00K, giving a free cash flow of -$14.05M billion.
Operating Cash Flow-$13.97M
Free Cash Flow-$14.05M
Free Cash Flow per Share-$0.40
Dividends & Yields
Monogram Orthopaedics Inc pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-18.20%
Earnings Yield-21.15%
Stock Price Statistics
Beta1.45
52-Week Price Change14.89%
50-Day Moving Average2.64
200-Day Moving Average2.53
Relative Strength Index (RSI)50.51
Average Volume (3m)1.31M
Important Dates
Monogram Orthopaedics Inc upcoming earnings date is May 20, 2025, Before Open.
Last Earnings DateMar 12, 2025
Next Earnings DateMay 20, 2025
Ex-Dividend Date―
Financial Position
Monogram Orthopaedics Inc as a current ratio of 10.57, with Debt / Equity ratio of 0.03
Current Ratio10.57
Quick Ratio10.57
Debt to Market Cap<0.01
Net Debt to EBITDA1.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Monogram Orthopaedics Inc has paid $2.00 in taxes.
Income Tax$2.00
Effective Tax Rate0.00%
Enterprise Valuation
Monogram Orthopaedics Inc EV to EBITDA ratio is -4.04, with an EV/FCF ratio of -4.41.
EV to Sales0.00
EV to EBITDA-4.04
EV to Free Cash Flow-4.41
EV to Operating Cash Flow-4.43
Balance Sheet
Monogram Orthopaedics Inc has $15.66M in cash and marketable securities with $364.00K in debt, giving a net cash position of -$15.29M billion.
Cash & Marketable Securities$15.66M
Total Debt$364.00K
Net Cash-$15.29M
Net Cash Per Share-$0.43
Tangible Book Value Per Share$0.43
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Monogram Orthopaedics Inc is $5.40, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$5.40
Price Target Upside97.80%
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-100.00%
EPS Growth Forecast8.75%